SE0601589L - Administration of opioids - Google Patents

Administration of opioids

Info

Publication number
SE0601589L
SE0601589L SE0601589A SE0601589A SE0601589L SE 0601589 L SE0601589 L SE 0601589L SE 0601589 A SE0601589 A SE 0601589A SE 0601589 A SE0601589 A SE 0601589A SE 0601589 L SE0601589 L SE 0601589L
Authority
SE
Sweden
Prior art keywords
opioids
administration
Prior art date
Application number
SE0601589A
Other languages
Swedish (sv)
Inventor
Gayatri Sathyan
Nipun Davar
Linda H Pors
Gemma Casadevall
Jayne Hastedt
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Priority to SE0602280A priority Critical patent/SE0602280L/en
Publication of SE0601589L publication Critical patent/SE0601589L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE0601589A 2005-10-31 2006-07-20 Administration of opioids SE0601589L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE0602280A SE0602280L (en) 2005-10-31 2006-10-30 Procedures for reducing alcohol-induced dose dumping for delayed-release oral opioid dosage forms

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73199505P 2005-10-31 2005-10-31
US80201706P 2006-05-18 2006-05-18

Publications (1)

Publication Number Publication Date
SE0601589L true SE0601589L (en) 2007-05-01

Family

ID=36758362

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0601589A SE0601589L (en) 2005-10-31 2006-07-20 Administration of opioids

Country Status (11)

Country Link
BG (1) BG1070U1 (en)
CA (6) CA2554697A1 (en)
CZ (1) CZ19137U1 (en)
DK (1) DK200600189U3 (en)
FI (1) FI7357U1 (en)
GB (1) GB0612326D0 (en)
IE (1) IES20060507A2 (en)
NL (1) NL1032148C1 (en)
NO (1) NO20063233L (en)
SE (1) SE0601589L (en)
SK (1) SK5202Y1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10736850B2 (en) 2007-08-13 2020-08-11 Ohemo Life Sciences Inc. Abuse resistant oral opioid formulations
EP2976082A4 (en) 2013-03-15 2016-05-11 Inspirion Delivery Technologies Llc Abuse deterrent compositions and methods of use
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
US10172842B2 (en) * 2015-09-11 2019-01-08 PharmaDax Inc. Sustained release oral dosage form containing dalfampridine

Also Published As

Publication number Publication date
FI7357U1 (en) 2007-01-16
NO20063233L (en) 2007-05-02
SK5202Y1 (en) 2009-06-05
FIU20060296U0 (en) 2006-07-12
NL1032148C1 (en) 2006-11-17
CA2554693A1 (en) 2007-04-30
CA2554698A1 (en) 2007-04-30
GB0612326D0 (en) 2006-08-02
CA2554684A1 (en) 2007-04-30
BG1070U1 (en) 2008-06-30
IES20060507A2 (en) 2007-05-30
CZ19137U1 (en) 2008-12-08
CA2554701A1 (en) 2007-04-30
CA2554697A1 (en) 2007-04-30
DK200600189U3 (en) 2007-02-23
SK50572006U1 (en) 2009-01-07
CA2554874A1 (en) 2007-04-30

Similar Documents

Publication Publication Date Title
CY2022001I1 (en) DERIVATIVE OF UK-2A
CY2014012I2 (en) ADMINISTRATION OF DIPEPTIDYLOPEPTIDASE INHIBITORS
DK1720866T3 (en) Course of action
DK1940467T3 (en) Long-release drug composition
DK2073795T3 (en) Abuse-safe drug formulation
DK1957073T3 (en) PHARMACEUTICAL
NO20055643D0 (en) Preparation of lodixanol
FI20065757A0 (en) Use of beta-lactamase
DE602007003775D1 (en) speaker
DK2035369T3 (en) THERAPEUTIC
DE602006019800D1 (en) Breading
NO20043305D0 (en) Preparation of lodixanol
NO20083139L (en) Use of elderberry extract
SE0601589L (en) Administration of opioids
FI20055133A0 (en) Type of device
BRPI0812832A2 (en) PHARMACEUTICAL COMBINATION OF OPIOIDS AND PROSTAGLANDINE COMPOUND
FR2877833B1 (en) CORRECTEUR OF LORDOSES
UA12944S (en) WALL OF THE PAVILION
TH101115B (en) Wardrobe
ITMO20040025A1 (en) MEANS OF CONNECTION
FI20041228A (en) Condition of sandstone
ITVR20050140A1 (en) STRUCTURE OF TRAMEZZO
ITVR20050133A1 (en) STRUCTURE OF MONILE
ITVI20050244A1 (en) STRUCTURE OF COLONNINA
ITPS20050012A1 (en) STRUCTURE OF PHYTO-DEPURATOR

Legal Events

Date Code Title Description
NAV Patent application has lapsed